SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate

SELLAS Life Sciences Group Inc +2.11%

SELLAS Life Sciences Group Inc

SLS

1.45

+2.11%

SELLAS Life Sciences Gr (NASDAQ: SLS) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 41.86 percent increase over losses of $(0.43) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via